Circulating Micro-RNAs as Biomarkers for Thoracic Radiation Therapy in Lung Cancer
Risk of normal tissues toxicity limits the amount of thoracic radiation therapy that can be routinely prescribed for the treatment of non-small cell lung cancer (NSCLC). An early biomarker of response to thoracic radiation may provide a way to predict eventual toxicities during the multi-week treat...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | en |
| Published: |
Harvard University
2016
|
| Online Access: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:27007756 |